Shareholding14 May 2026, 08:29 am
Gaurang Thakker Increases Stake in Aptus Pharma to 8.64%
AI Summary
Gaurang Thakker has increased his stake in Aptus Pharma Limited to 8.64% through an off-market inter-se transfer among promoters, acquiring 18,000 shares on May 11, 2026. This acquisition falls under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. Before the acquisition, Thakker held 5,75,000 shares (8.38%). Post-acquisition, his holding stands at 5,93,000 shares. The equity share capital of Aptus Pharma remains unchanged at 68,60,000 equity shares of ₹10 each.
Key Highlights
- Gaurang Thakker acquired 18,000 shares of Aptus Pharma on May 11, 2026.
- Thakker's stake in Aptus Pharma increased from 8.38% to 8.64%.
- The acquisition was an off-market inter-se transfer among promoters.
- The acquisition is governed by SEBI's Takeover Regulations.
- Aptus Pharma's equity share capital remains at 68,60,000 shares.
Price Impact
More from APPL